Czech National Bank Buys 3,363 Shares of The Cigna Group (NYSE:CI)

Czech National Bank grew its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 5.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 60,310 shares of the health services provider's stock after purchasing an additional 3,363 shares during the quarter. Czech National Bank's holdings in The Cigna Group were worth $16,654,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the business. AQR Capital Management LLC boosted its holdings in shares of The Cigna Group by 63.4% during the 2nd quarter. AQR Capital Management LLC now owns 1,547,245 shares of the health services provider's stock worth $510,467,000 after buying an additional 600,215 shares during the period. Ameriprise Financial Inc. boosted its holdings in The Cigna Group by 23.4% during the second quarter. Ameriprise Financial Inc. now owns 2,138,193 shares of the health services provider's stock valued at $706,822,000 after acquiring an additional 405,694 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in The Cigna Group by 145.3% during the second quarter. The Manufacturers Life Insurance Company now owns 683,361 shares of the health services provider's stock valued at $225,899,000 after acquiring an additional 404,791 shares during the period. International Assets Investment Management LLC grew its position in shares of The Cigna Group by 49,287.7% in the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider's stock valued at $138,590,000 after purchasing an additional 399,230 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ increased its stake in shares of The Cigna Group by 526.3% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 363,537 shares of the health services provider's stock worth $120,174,000 after purchasing an additional 305,490 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Price Performance

The Cigna Group stock traded up $2.50 during mid-day trading on Tuesday, hitting $284.95. 2,173,146 shares of the company were exchanged, compared to its average volume of 1,420,818. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The business has a fifty day moving average of $303.49 and a 200 day moving average of $327.70. The company has a market capitalization of $79.26 billion, a PE ratio of 26.88, a price-to-earnings-growth ratio of 0.88 and a beta of 0.54.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm's quarterly revenue was up 29.8% on a year-over-year basis. During the same period last year, the firm posted $6.77 EPS. As a group, sell-side analysts expect that The Cigna Group will post 28.5 earnings per share for the current year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 19th. Investors of record on Wednesday, December 4th were given a dividend of $1.40 per share. The ex-dividend date was Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.97%. The Cigna Group's dividend payout ratio (DPR) is presently 52.83%.

Analysts Set New Price Targets

CI has been the topic of a number of research analyst reports. StockNews.com lowered The Cigna Group from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, October 23rd. Barclays increased their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the company an "overweight" rating in a report on Tuesday, November 5th. Piper Sandler restated an "overweight" rating and set a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Finally, Stephens reiterated an "overweight" rating and issued a $410.00 target price on shares of The Cigna Group in a research note on Friday, November 1st. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of $395.93.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.